2017
DOI: 10.1016/j.jcis.2017.03.057
|View full text |Cite
|
Sign up to set email alerts
|

Exfoliated graphene nanosheets: pH-sensitive drug carrier and anti-cancer activity

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
15
0

Year Published

2017
2017
2021
2021

Publication Types

Select...
6
1

Relationship

1
6

Authors

Journals

citations
Cited by 39 publications
(15 citation statements)
references
References 70 publications
0
15
0
Order By: Relevance
“…The results of the MTT test also confirm a decrease in cell viability due to the action of graphene oxide. Studies by Tyagi et al [ 30 ] indicate a time-dependence for cells exposed to graphene oxide, where the likely cause of growth inhibition, as they describe, is the lack of access to nutrients caused by the deposition of graphene oxide aggregates on cells. As in the present study, Changa et al [ 31 ] indicate that a significant decrease in cell survival is noticeable at higher concentrations, and Seabra and his team [ 32 ] confirm that cell viability is influenced by concentrations of graphene oxide above 100 μg/mL.…”
Section: Discussionmentioning
confidence: 99%
“…The results of the MTT test also confirm a decrease in cell viability due to the action of graphene oxide. Studies by Tyagi et al [ 30 ] indicate a time-dependence for cells exposed to graphene oxide, where the likely cause of growth inhibition, as they describe, is the lack of access to nutrients caused by the deposition of graphene oxide aggregates on cells. As in the present study, Changa et al [ 31 ] indicate that a significant decrease in cell survival is noticeable at higher concentrations, and Seabra and his team [ 32 ] confirm that cell viability is influenced by concentrations of graphene oxide above 100 μg/mL.…”
Section: Discussionmentioning
confidence: 99%
“…Moreover, a recent study shows that the graphene nanosheet has the dual role as a nanocarrier for the anti-cancer drug, and also acts as an anti-cancer agent [ 15 ]. In the research conducted by Tyagi et al [ 15 ], the graphene nanosheets were exfoliated by using poly(vinylpyrrolidone) nanoparticles (PVP-NP), which have higher concentrations of loaded drug caused significant cytotoxicity against both mouse embryonic fibroblasts (NIH-3T3) and human colorectal cancer cells (HCT-116). As shown in Figure 2 , the toxic effect of graphene-poly(vinylpyrrolidone) nanoparticle composite (GRP-PVP-NP) against cancer cells is visualized.…”
Section: Biomedical Applicationmentioning
confidence: 99%
“… Schematic diagram of potential mechanism with graphene-poly(vinylpyrrolidone) nanoparticle composite (GRP-PVP-NP) induced cytotoxicity in cancer cells [ 15 ]. …”
Section: Figurementioning
confidence: 99%
“…This has been investigated for several polymer nanocomposites and carbon‐based materials for different applications . Furthermore, in one of our recent studies polymer nanoparticles of an average size of 42 nm were used for the exfoliation of graphene sheets and specifically their drug delivery properties were studied …”
Section: Introductionmentioning
confidence: 99%
“…[31,32] Furthermore, in one of our recent studies polymer nanoparticles of an average size of 42 nm were used for the exfoliation of graphene sheets and specifically their drug delivery properties were studied. [33] In this study, graphene sheets were exfoliated by an onepot method using ultrasonication in aqueous solution of the polymer nanoparticles. In addition, poly(vinylpyrrolidone) (PVP) nanoparticles of different sizes have been prepared by using an environmentally friendly method and employed for the graphene exfoliation.…”
Section: Introductionmentioning
confidence: 99%